Tacita Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.1K Sell
94
-17
-15% -$8.16K 0.03% 145
2026
Q1
$54.6K Hold
111
0.03% 137
2025
Q4
$64.3K Hold
111
0.04% 130
2025
Q3
$53.8K Buy
111
+17
+18% +$7.91K 0.03% 138
2025
Q2
$38.1K Hold
94
0.02% 155
2025
Q1
$46.8K Hold
94
0.03% 137
2024
Q4
$48.9K Hold
94
0.03% 126
2024
Q3
$58.1K Hold
94
0.04% 143
2024
Q2
$52K Hold
94
0.04% 145
2024
Q1
$54.6K Hold
94
0.04% 147
2023
Q4
$49.9K Hold
94
0.04% 145
2023
Q3
$47.6K Hold
94
0.04% 146
2023
Q2
$49K Hold
94
0.04% 142
2023
Q1
$54K Hold
94
0.04% 131
2022
Q4
$52K Hold
94
0.04% 127
2022
Q3
$48K Hold
94
0.04% 122
2022
Q2
$51K Hold
94
0.04% 133
2022
Q1
$56K Hold
94
0.03% 137
2021
Q4
$63K Hold
94
0.04% 124
2021
Q3
$54K Hold
94
0.03% 129
2021
Q2
$47K Hold
94
0.03% 151
2021
Q1
$43K Hold
94
0.03% 156
2020
Q4
$44K Buy
+94
New +$44.1K 0.03% 158

Other funds holding TMO

Tacita Capital's TMO Position: Q2 2026 in Review

Tacita Capital reduced its Thermo Fisher Scientific (TMO) stake by 15% in Q2 2026, selling an estimated $8.16K and leaving 94 shares worth $47.1K. The position accounts for 0.03% of the portfolio, ranked #145.

Tacita Capital first reported a position in TMO in Q4 2020 and has held it in 23 quarters since. The position peaked at $64.3K in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Tacita Capital held 94 shares of Thermo Fisher Scientific worth $47.1K as of Q2 2026.
  • Tacita Capital sold 17 Thermo Fisher Scientific shares in Q2 2026, an estimated $8.16K.
  • Thermo Fisher Scientific made up 0.03% of Tacita Capital's portfolio in Q2 2026, its #145 holding.
  • Tacita Capital first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 23 quarters since.
  • Tacita Capital's Thermo Fisher Scientific position peaked at $64.3K in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Tacita Capital's 13F filing for Q2 2026, filed 10 Aug 2026.